Eris Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on November 24, 2025.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences Limited has submitted a filing to NSE notifying the outcome of its Board Meeting held on November 24, 2025. The announcement as provided does not include specific details about the decisions, approvals, or resolutions passed during the meeting. This is a standard regulatory disclosure under SEBI listing norms, where companies are required to inform the exchanges about the outcome of board meetings within stipulated timelines. Investors will need to refer to the detailed filing or the company's official communication to understand any financial, strategic, or governance decisions taken at this meeting.
No direct impact on shareholders can be assessed from this brief notification alone, as the actual decisions or outcomes are not included in the filing text. Investors should look for the detailed outcome document to evaluate any potential impact on the stock or company strategy.